Presentation Information
[2-PL-03].
*Yukinari Kato1 (1. Dep. Antibody Drug Development, Grad. Sch. Med., Tohoku Univ.)
Keywords:
antibody drug,tumor
Comment
To browse or post comments, you must log in.Log in
antibody drug,tumor
To browse or post comments, you must log in.Log in